A common ABCC2 promoter polymorphism is not a determinant of the risk of spina bifida

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 6, 2004, Pages 396-399

  Jensen, Liselotte E ^a   Wall, Amelia M ^b   Cook, Michelle ^a   Hoess, Katy ^a   Thorn, Caroline F ^a,d   Whitehead, Alexander S ^a   Mitchell, Laura E ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Association study; Birth defect; Folate efflux; Neural tube defect

Indexed keywords

ABC TRANSPORTER; FOLIC ACID; FOLIC ACID ANTAGONIST; HOMOCYSTEINE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 2;

ABCC2 GENE; ARTICLE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; METABOLIC DISORDER; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SPINA BIFIDA;

ATP-BINDING CASSETTE TRANSPORTERS; FOLIC ACID; HOMOCYSTEINE; HUMANS; LIKELIHOOD FUNCTIONS; LINEAR MODELS; NEURAL TUBE DEFECTS; PEDIGREE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL DYSRAPHISM; VARIATION (GENETICS);

EID: 3042723620     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20023     Document Type: Article

References (30)

1. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. N Eng J Med 341:1485-1490.
2. Berry RJ, Li Z. 2002. Folic acid alone prevents neural tube defects: evidence from the China study. Epidemiology 13:114-116.
3. Botto LD, Yang Q. 2000. 5,10-methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862-877.
4. Brody LC, Conley M, Cox C, et al. 2002. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the birth defects research group. Am J Hum Genet 71:1207-1215.
5. Brown KS, Cook M, Hoess K, et al. 2004. Evidence that the risk of spina bifida is influenced by genetic variation at the NOS2 locus. Birth Defects Res Part A Clin Mol Teratol 70:101-106.
6. Curtis D, Sham PC. 1995. A note on the application of the transmission disequilibrium test when a parent is missing. Am J Hum Genet 56:811-821.
7. Czeizel A, Dudas I. 1992. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Eng J Med 327:1832-1835.
8. Doolin M-T, Barbaux SMM, Hoess K, et al. 2002. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 71:1222-1226.
9. Hooijberg JH, Broxterman HJ, Kool M, et al. 1999. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res 59:2532-2535.
10. Kirke PN, Molloy AM, Daly LE, et al. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. QJM 86:703-708.
11. Lucock MD, Daskalakis I, Lumb CH, et al. 1998. Impaired regeneration of monoglutamyl tetrahydrofolate leads to cellular folate depletion in mothers affected by a spina bifida pregnancy. Mol Genet Metab 65:18-30.
12. Mills JL, McPartlin JM, Kirke PN, et al. 1995. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345:149-151.
13. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
14. Northrup H, Volcik KA. 2000. Spina bifida and other neural tube defects. Curr Probl Pediatr 30:313-332.
15. Online Medelian Inheritance in Man (OMIM). (http://www.ncbi.nlm.nih. gov/omim).
16. Paulusma CC, Bosma PJ, Zaman GJ, et al. 1996. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271:1126-1128.
17. Shani M, Seligsohn U, Gilon E, et al. 1970. Dubin-Johnson syndrome in Israel. I. Clinical, laboratory and genetic aspects of 101 cases. QJM 39:549-567.
18. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
19. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al. 1994. Maternal hyperhomocysteinemia: a risk factor for neural tube defects? Metabolism 43:1475-1480.
20. Steegers-Theunissen RPM, Boers GH, Blom HJ, et al. 1995. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 172:1436-1441.
21. van den Oord EJCG, Vermunt JK. 2000. Testing for linkage disequilibrium, maternal effects, and imprinting with (in)complete case-parent triads, by use of the computer program LEM. Am J Hum Genet 66:335-338.
22. Vermunt JK. 1997. LEM: a general program for the analysis of categorical data Tilberg University, Tilberg, the Netherlands.
23. Walker AH, Najarian D, White DL, et al. 1999. Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays. Environ Health Perspect 107:517-520.
24. Weinberg CR, Wilcox AJ, Lie RT. 1998. A log-linear approach to case-parent-triad data: assessing the effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62:969-978.
25. Weinberg CR. 1999. Allowing for missing parents in genetic studies of case-parent triads. Am J Hum Genet 64:1186-1193.
26. Wenstrom KD, Johanning GL, Owen J, et al. 2000. Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrafolate reductase genotypes, and neural tube closure sites. Am J Med Genet 90:6-11.
27. Wilcox AJ, Weinberg CR, Lie RT. 1998. Distinquishing the effects of maternal and offspring genes through studies of "case-parent triads". Am J Epidemiol 148:893-901.
28. Wilson A, Platt R, Wu Q, et al. 1999. A common variant of methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 67:317-323.
29. Wolkoff AW, Cohen LE, Arias IM. 1973. Inheritance of Dubin-Johnson syndrome. N Eng J Med 288:113-117.
30. Zhu H, Wicker NJ, Shaw GM, et al. 2003. Homocysteine remethylation enzyme polymorphisms and increased risk for neural tube defects. Mol Genet Metab 78:216-221.